DK0821693T3 - Nye DNA-sekvenser fra human cytomegalovirus (HCMV) - Google Patents

Nye DNA-sekvenser fra human cytomegalovirus (HCMV)

Info

Publication number
DK0821693T3
DK0821693T3 DK96910560T DK96910560T DK0821693T3 DK 0821693 T3 DK0821693 T3 DK 0821693T3 DK 96910560 T DK96910560 T DK 96910560T DK 96910560 T DK96910560 T DK 96910560T DK 0821693 T3 DK0821693 T3 DK 0821693T3
Authority
DK
Denmark
Prior art keywords
hcmv
dna sequences
human cytomegalovirus
new human
sequences
Prior art date
Application number
DK96910560T
Other languages
Danish (da)
English (en)
Inventor
Tai-An Cha
Richard Spaete
Original Assignee
Medimmune Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medimmune Vaccines Inc filed Critical Medimmune Vaccines Inc
Application granted granted Critical
Publication of DK0821693T3 publication Critical patent/DK0821693T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/405—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from algae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK96910560T 1995-03-31 1996-03-26 Nye DNA-sekvenser fra human cytomegalovirus (HCMV) DK0821693T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/414,926 US5721354A (en) 1995-03-31 1995-03-31 Human cytomegalovirus DNA sequences
PCT/US1996/004100 WO1996030387A1 (en) 1995-03-31 1996-03-26 Novel human cytomegalovirus dna sequences

Publications (1)

Publication Number Publication Date
DK0821693T3 true DK0821693T3 (da) 2003-12-22

Family

ID=23643613

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96910560T DK0821693T3 (da) 1995-03-31 1996-03-26 Nye DNA-sekvenser fra human cytomegalovirus (HCMV)

Country Status (11)

Country Link
US (7) US5721354A (de)
EP (1) EP0821693B1 (de)
JP (1) JP3658411B2 (de)
AT (1) ATE248184T1 (de)
AU (1) AU706234B2 (de)
CA (1) CA2215328C (de)
DE (1) DE69629674T2 (de)
DK (1) DK0821693T3 (de)
ES (1) ES2206569T3 (de)
PT (1) PT821693E (de)
WO (1) WO1996030387A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721354A (en) * 1995-03-31 1998-02-24 Aviron Human cytomegalovirus DNA sequences
FR2762601B3 (fr) * 1997-04-29 1999-06-04 Bio Merieux Polypeptide capable de reagir avec les anticorps de patients atteints de sclerose en plaques et utilisations
FR2762600B1 (fr) * 1997-04-29 1999-11-05 Bio Merieux Polypeptide capable de reagir avec les anticorps de patients atteints de sclerose en plaques et utlisations
WO2000034335A2 (en) * 1998-12-04 2000-06-15 Schering Corporation 'death domain' containing receptors
JP3877894B2 (ja) * 1999-01-13 2007-02-07 三菱電機株式会社 車両用ブラシレス交流発電機
EP2039368A3 (de) 1999-04-30 2009-04-01 La Jolla Institute For Allergy And Immunology Verfahren zur Vorbeugung der Reaktivierung von latenten Viren und Überwachung der Virenreplikation
AU1578801A (en) * 1999-11-05 2001-06-06 Human Genome Sciences, Inc. 29 human secreted proteins
GB0024283D0 (en) * 2000-10-04 2000-11-15 Inpharmatica Ltd Novel proteins
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
US7204990B1 (en) * 2000-11-28 2007-04-17 Medimmune Vaccines, Inc. Attenuation of cytomegalovirus virulence
CA2441548A1 (en) * 2001-03-22 2002-10-03 Incyte Genomics, Inc. Adenylyl and guanylyl cyclases
RU2218408C2 (ru) * 2001-11-05 2003-12-10 Государственный научный центр вирусологии и биотехнологии "Вектор" РЕКОМБИНАНТНАЯ ПЛАЗМИДНАЯ ДНК pUL83HCMV, ОБЕСПЕЧИВАЮЩАЯ ЭКСПРЕССИЮ В КЛЕТКАХ БАКТЕРИИ Escherichia coli РЕКОМБИНАНТНОГО БЕЛКА, СОДЕРЖАЩЕГО ИММУНОДОМИНАНТНУЮ ЧАСТЬ ФОСФОПРОТЕИНА pp65 HCMV И ФРАГМЕНТ β-ГАЛАКТОЗИДАЗЫ
WO2004033490A2 (en) * 2002-10-09 2004-04-22 University College Cardiff Consultants Limited Hcmv derived immunomodulatory polypeptide
WO2004058166A2 (en) * 2002-12-23 2004-07-15 Vical Incorporated Codon-optimized polynucleotide-based vaccines against human cytomegalovirus infection
GB0400965D0 (en) * 2004-01-16 2004-02-18 Glaxo Group Ltd Promoter
US8088902B2 (en) * 2004-04-05 2012-01-03 The Rockefeller University DNA virus microRNA and methods for inhibiting same
WO2006004661A1 (en) * 2004-06-25 2006-01-12 Medimmune Vaccines, Inc. Recombinant human cytomegalovirus and vaccines comprising heterologous antigens
US20140348863A1 (en) * 2011-10-12 2014-11-27 Alessia Bianchi Cmv antigens and uses thereof
US20200182884A1 (en) 2016-06-27 2020-06-11 Juno Therapeutics, Inc. Method of identifying peptide epitopes, molecules that bind such epitopes and related uses
CN118834290B (zh) * 2024-06-04 2025-10-03 杭州迪安医学检验中心有限公司 一种人巨细胞病毒ul135蛋白抗体及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075213A (en) * 1984-07-27 1991-12-24 City Of Hope Method for detection and prevention of human cytomegalovirus infection
US5194256A (en) * 1984-08-21 1993-03-16 The Board Of Trustees Of The Leland Sanford Junior University Purified human cytomegalovirus protein
US5721354A (en) * 1995-03-31 1998-02-24 Aviron Human cytomegalovirus DNA sequences

Also Published As

Publication number Publication date
EP0821693A1 (de) 1998-02-04
EP0821693B1 (de) 2003-08-27
JP3658411B2 (ja) 2005-06-08
AU706234B2 (en) 1999-06-10
US20060240446A1 (en) 2006-10-26
ATE248184T1 (de) 2003-09-15
CA2215328A1 (en) 1996-10-03
ES2206569T3 (es) 2004-05-16
US6040170A (en) 2000-03-21
DE69629674T2 (de) 2004-07-08
US20040001850A1 (en) 2004-01-01
US5721354A (en) 1998-02-24
EP0821693A4 (de) 1999-09-08
DE69629674D1 (de) 2003-10-02
PT821693E (pt) 2004-01-30
US7208165B2 (en) 2007-04-24
US6635477B1 (en) 2003-10-21
US6291236B1 (en) 2001-09-18
AU5372796A (en) 1996-10-16
CA2215328C (en) 2011-05-31
US5925751A (en) 1999-07-20
WO1996030387A1 (en) 1996-10-03
JPH11503013A (ja) 1999-03-23

Similar Documents

Publication Publication Date Title
EP0821693A4 (de) Dns-sequenzen des humanen cytomegaloviruses
TR200806259T2 (tr) Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
DK0774974T3 (da) Nucleinsyrevaccine
PT757717E (pt) Vacinas de papilomavirus
EP0773294A3 (de) Leistungsfähiges System zur gerichteten genetischen Klonierung
FI962247A7 (fi) Uudet apoptoosia muuntavat proteiinit, niitä koodaava DNA ja näiden kä yttömenetelmät
DE69632625D1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
DE69729302T2 (de) Illudin analoge verwendet als antitumormittel
NZ504669A (en) Virulence-associated nucleic acid sequences and uses in identification of anti-virulence agents
DE69610748D1 (de) Polyoxyalkylenblockcopolymere, Verfahren zur Herstellung und ihre Verwendung als Schmiermittel
MX9806041A (es) Proteina purificada sr-p70.
ATE341339T1 (de) Zusammensetzungen von rekombinanten papillomavirus vakzinen
SE9602822D0 (sv) New receptor
NO981195D0 (no) Nye aminoresin sammensetninger
EE04944B1 (et) Bakteriaalsed plasmiidid kasutamiseks ekspressioonivektoritena v?i mikrobioloogilisel analsil
ES2165358T3 (es) Utilizaciones de la proteinquinasa de neurofilamento/tau pk40.
IL139495A0 (en) Moraxella catarrhalis proteins
ATE320266T1 (de) Induktion von antigen-spezifischen t-zellen durch interferon
ATE313628T1 (de) Klonierung und expression von haemophilus somnus transferrin-bindenden proteinen
CA2177600A1 (fr) Sequences d'acides nucleiques regulatrices et utilisations
SE9604439D0 (sv) New receptor
NZ330913A (en) Antigens for preventing and reducing parasite infection and disease
AU2002213725A1 (en) Method for the detection of human hematopoietic short term repopulating cells
FI920885A7 (fi) Bakteerien ilmaiseminen nukleiinihappoamplifikaation avulla
ITVE950001V0 (it) Concio in laterizio per la realizzazione di architravi laterocementizi